Pure Global AI
TFDA market access

Taiwan medical device registration resources

Research TFDA registration records, classification, regulations, timelines, fees, and market updates — the stable entrance to every Taiwan medical device resource.

89,088 license records11 free resources24/25 topics with records30 regulations trackedAug 2026 fees reviewed

Everything we track for Taiwan

Browse by resource instead →

Structured regulatory requirements

Explore all 80 source-linked facts →

24 of 25 research dimensions currently covered · 29 official sources · latest verification 2026-09-15

Market entry

D01

Authority & regime

Verified
Commissioned institutions conduct training and QMS/GDP inspections
The central authority may commission legal entities or associations to run technical personnel training and to conduct device firm inspections covering Act Art. 22 QMS matters and Act Art.…
Competent authority
Ministry of Health and Welfare (MOHW) is the competent authority at the central level for medical devices; municipal and county/city governments are the local competent authorities. The Min…
2 source-linked facts
Checked 2026-08-28
Open details →
D02

Legal basis & guidance

Verified
Primary legislation and effective date
Medical Device Act (醫療器材管理法), 85 articles, promulgated 2020 01 15 by Presidential Order 華總一義字第10900004021號; effective date 2021 05 01 fixed by Executive Yuan Order 行政院院臺衛字第1100001220號 (issu…
Transition from Pharmaceutical Act
From the Medical Device Act's effective date, device matters are governed by the Medical Device Act and the device provisions of the Pharmaceutical Act (藥事法) cease to apply.
2 source-linked facts
Checked 2026-08-25
Open details →
D03

Device definition & scope

Verified
Medical device definition
Medical device means instruments, apparatus, appliances, materials, software, in vitro diagnostic reagents and related articles whose design and use act on the human body by means other tha…
Software and IVDs inside the definition
Software (軟體) and in vitro diagnostic reagents (體外診斷試劑) are explicitly named within the statutory definition of medical device, so SaMD and IVDs fall under the same regime (no separate IVD…
2 source-linked facts
Checked 2026-08-25
Open details →
D04

Classification rules

Verified
Risk classes I through III.
Class I, Class II, Class III
1 maintained scheme
Checked 2026-08-25
Open details →
D05

Registration pathways

Verified
Class I filing process
Class I filing (登錄) is done in the central authority's online medical device filing system: the applicant enters product name, firm and manufacturer data, classification item code, sterilis…
Registration vs filing routes
Manufacture or import of a medical device requires registration (查驗登記) with the central authority and a medical device licence (醫療器材許可證); however, item categories announced by the central a…
3 source-linked facts
Checked 2026-08-25
Open details →
D06

Reliance & recognition

Verified
China NMPA approval: origin evidence only
statement: TFDA import registration for Class II/III devices requires an original 出產國許可製售證明 (certificate that the device is approved for manufacture and free sale) issued by the highest hea…
China-made devices: MOEA import permission required before TFDA registration
statement: Taiwan does not recognise NMPA approval and additionally restricts PRC origin devices: 附表二 說明十三(三) provides that a device manufactured in China may only be submitted for TFDA reg…
4 source-linked facts
Checked 2026-09-15
Open details →
D07

Economic-operator roles

Verified
Contract manufacturing approval, registration and liability
Contract manufacturing means entrusting the full process (manufacture, packaging, labelling, sterilisation and final release) or the manufacturing/sterilisation steps to another device manu…
Outsourced distribution activities need written contracts
Where a distributor outsources import, storage, transport, sale, protection or servicing to another party, the arrangement must be covered by a written contract and monitored wherever it ca…
5 source-linked facts
Checked 2026-08-28
Open details →
D08

Establishment, import & distribution

Verified
Medical device business permit
To operate as a medical device firm (manufacturer or distributor, including importers), the company must be approved and registered with the municipal or county/city government health autho…
GDP system and distribution permit
Distributors of announced device categories must establish a good distribution practice (優良運銷) system per the GDP Regulations and pass central authority inspection to obtain a distribution…
11 source-linked facts
Checked 2026-08-28
Open details →
D09

Dossier requirements

Verified
Class I registration dossier
Class I registration applications must include the documents and data of Annex 1 (documents for Class I device registration for manufacture or import); the central authority may decline to…
Class II/III registration dossier
Class II and III registration applications must include the documents and data of Annexes 2 and 3, which include (per the regulation's definitions and extension article) the country of orig…
4 source-linked facts
Checked 2026-08-25
Open details →
D10

Official forms & portals

Verified
Official submission systems
Official channels: the medical device registration electronic submission system (醫療器材查驗登記電子化送件系統, https://mds.fda.gov.tw/) for Class I (non filing) registration, Class II/III registration,…
1 source-linked fact
Checked 2026-08-25
Open details →

Submission & evidence

D11

Label, IFU & language

Verified
Chinese label and IFU
Devices may only be sold, wholesaled or retailed with a Chinese label on the smallest sales package and an accompanying Chinese instruction for use (except where announced or approved other…
1 source-linked fact
Checked 2026-08-25
Open details →
D12

QMS, audit & inspection

Verified
Sterilisation and packaging equipment requirements
Manufacturers performing sterilisation must be equipped with sterilisation equipment and sterility testing equipment (the latter excused where sterility testing is not performed). Packaging…
Unannounced GDP inspections
The central authority may conduct unannounced inspections of distributor premises at any time without prior notice. Municipal/county authorities may be invited to join. Inspectors must show…
7 source-linked facts
Checked 2026-08-28
Open details →
D13

Standards, testing & ancillary approvals

Unresolved
TFDA electrical/EMC evidence
Electrical safety
NCC Type Approval/DoC/simplified DoC
Wireless / radio
BSMI inspection/certification
Adapters / components
4 maintained overlays · 3 related facts
Checked 2026-08-28
Open details →
Class I device registration (查驗登記)
TWD 15,000
Class II device registration (查驗登記)
TWD 58,000
24 maintained fee lines
Checked 2026-08-25
Open details →
D15

Review clocks

Verified
Class I · Registration
80 days
Class II · Registration
140 days
Class III · Registration with clinical data
200 days
4 maintained pathways · 1 related fact
Checked 2026-08-29
Open details →
D16

Approval validity & renewal

Verified
Class I annual declaration
Class I filers whose filing has been complete for one year must perform an annual declaration (年度申報) each October in the filing system, confirming the filed particulars and paying the annua…
Licence duration
The manufacture/import licence is valid for a maximum of five years from the issuance date. To continue, an extension must be approved before expiry; each extension may not exceed five year…
5 source-linked facts
Checked 2026-08-28
Open details →

Lifecycle & post-market

D17

Change control

Verified
Changes requiring prior approval
Changes to items designated by the central authority require prior approval (Act Art. 26). The licence regulation lists ten approval required change items: Chinese product name; English pro…
Self-managed minor changes
Minor label/packaging changes need no prior approval: (a) changes that do not alter the approved text (materials/graphics, proportional resizing, font changes, adding printed outer boxes),…
2 source-linked facts
Checked 2026-08-25
Open details →
D18

UDI, listing & traceability

Verified
Single identification and implantable traceability in manufacture
Manufacturers must operate a written product identification and traceability procedure. For device categories announced by risk level under Act Art. 19(1), a written single identification s…
GDP traceability record contents
Distributors must operate a written traceability procedure for product source and flow. The records must carry the device name, batch number, receipt date and quantity, shelf life, supplier…
5 source-linked facts
Checked 2026-08-28
Open details →
D19

Clinical investigation & performance

Verified
Sponsor GCP obligations
Sponsors must define, execute and manage the clinical trial and ensure data integrity and subject rights, safety and welfare (GCP Regulations Art. 5; investigator initiated trials are subje…
Clinical trial approval requirement
Sponsors or trial institutions must obtain central authority approval before starting a medical device clinical trial; announced non significant risk device trials are exempt from prior app…
3 source-linked facts
Checked 2026-08-25
Open details →
D20

Special access & derogation

Verified
Personal-use import limits
Personal use import (無需醫師或專業人員操作、由自然人自行使用之醫療器材) is limited: consumables to a six month supply, instruments to one unit per model; expedited clearance for listed items and quantities is limi…
Project approval applicant eligibility per ground
Each project approval ground under Act Art. 35(1) has defined eligible applicants: (1) prevention/diagnosis/treatment of life threatening or seriously disabling disease — regional teaching…
4 source-linked facts
Checked 2026-08-28
Open details →
D21

Manufacturer PMS

Verified
Monitoring period and report frequency
The safety monitoring period runs three years from the licence issuance, filing, announcement or designation date (extendable where necessary). Periodic reports are due semi annually: the d…
Safety monitoring duty
For devices approved or filed, the central authority may order the device firm to conduct safety monitoring under an approved monitoring plan; firms must prepare periodic safety monitoring…
3 source-linked facts
Checked 2026-08-28
Open details →
D22

Vigilance & incident reporting

Verified
Licence holder deadline
The licence holder or filer must complete the report within 15 days of discovering the event, then proactively investigate and evaluate corrective and preventive measures (reporting records…
Medical care institution deadlines and channel
Medical care institutions report within 7 days of discovery for death or life threatening events and within 15 days for other serious events. Reporting is done via the central authority's d…
3 source-linked facts
Checked 2026-08-25
Open details →
D23

Recall, FSCA & market surveillance

Verified
Disposal of recalled devices and trading stop
From the announcement, legal determination or permit revocation date, medical care institutions and device firms must stop importing, manufacturing, wholesaling, retailing or displaying the…
Distributor recall and reporting procedures with annual effectiveness review
Distributors must maintain operating procedures for serious adverse event reporting (Act Art. 48(1)), Act Art. 49 notifications, corrective and preventive measures, and Act Art. 58 recall n…
5 source-linked facts
Checked 2026-08-28
Open details →
D24

Advertising, claims & promotion

Verified
Advertising prior approval
Before publishing medical device advertising, the licence holder or filer must apply to the municipal or central authority with the advertising content for approval; after approval the hold…
Professional-audience restriction and prohibited practices
Devices whose IFU states they must be used by healthcare professionals (and announced devices) may only be advertised in media aimed exclusively at healthcare professionals or at profession…
2 source-linked facts
Checked 2026-08-25
Open details →
D25

Submission communications & appeal

Verified
Objection and appeal against fines
Against administrative fine decisions, the party may submit a written objection and request review within 15 days of delivery of the decision notice (once only); if unresolved, administrati…
Reconsideration of registration decisions
Applicants whose registration, filing or clinical trial applications are not approved may file one reconsideration request (申復) within four months of delivery of the decision, on procedural…
2 source-linked facts
Checked 2026-08-25
Open details →

TFDA registration fees in TWD · reviewed 2026-08-25

Fee lineAmountProvenance
Class I device registration (查驗登記)TWD 15,000Verified
Class II device registration (查驗登記)TWD 58,000Verified
Class III device registration (查驗登記)TWD 100,000Verified
Export-only device registrationTWD 15,000Verified
20 more fee lines on the full schedule · 24 of 24 rows source-verified

Registration timeline

Full registration timeline →

Taiwan Food and Drug Administration (TFDA) review clocks and planning ranges · 3-class (I, II, III) classification

Class / pathwayReview clockPlanning totalProvenance
Class I(Registration)80 days3-7 monthsVerified
Class II(Registration)140 days9-14 monthsVerified
Class III(Registration with clinical data)200 days1-1.5 yearsVerified
No-predicate device(Registration of a device with no similar marketed product)220 days1-2 yearsVerified
  1. 1Pre-Submission Preparation(1-3 months)
  2. 2Application Submission(1-2 weeks)
  3. 3Administrative Review(2-4 weeks)
  4. 4Technical Evaluation(80 days)
  5. 5Registration Approval(1-2 weeks)

Latest regulation news

All Taiwan regulation news →

Newest official TFDA headlines from the daily-refreshed feed — every row links directly to the authority publication.

Official TFDA rules and guidance · 30 of 30 documents linked to official sources

醫療器材行政規費收費標準Standards for Medical Device Administrative Fees
GeneralVerified
Regulations Governing Border Inspection and Examination of Imported Medical DevicesRegulations Governing Border Inspection and Examination of Imported Medical Devices
RegistrationVerified
Classification SystemApplication for the Classification of Medical Devices
ClassificationVerified
L0030120 AnnexMedical Device Classification Items — Official Annex
ClassificationVerified

Computed from 89,088 official TFDA license records · data as of 2024-12-24

New licenses by year
2018201920202021202220232024
VerifiedTFDA registry · as of 2024-12-24
45,899
Active licenses
13,462
Manufacturers
4,831
License Holders
59
Origin countries
Continue with this market

Turn Taiwan research into practical work

The target market is carried into each tool. Add the product, evidence, or regulatory change you want to assess.

View every AI workpaper →
Country hubs in other markets

Other East Asia & Pacific markets

DJ Fang
Entering the Taiwan market?
Local representation, TFDA submissions, and lifecycle maintenance — handled with an expert.
Pricing